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Tailoring the initial vascular access for dialysis patients. hemodialysis [1]. At that time diabetes was considered
Background. Creating a functioning initial arteriovenous a contraindication to dialysis treatment [2].
(AV) access for aging and diabetic end-stage renal disease Patient characteristics have changed during the subse-(ESRD) hemodialysis patients has been a challenge.
quent three decades. Worldwide, diabetics represent theMethods. This study describes 748 consecutive primary AV
most rapidly growing group of patients treated for end-access creations and their primary (unassisted) and secondary
(assisted) access survival at a single center. Twenty-four per- stage renal disease (ESRD) [3–5]. Geographical differ-
cent of the patients had diabetes as their cause of ESRD and ences are well known. In the U.S., the percentage of
the average age was 59.6 years. No patient receiving an initial incident patients with diabetes as the cause of ESRDAV access required synthetic graft material. All received an
exceeds 40%, with an additional 10% of patients havingAV fistula. Three types of fistulae were created and their distri-
diabetes as a comorbid condition. The correspondingbution varied significantly for diabetic and non-diabetic pa-
tients (respective percentages): forearm AV fistula (24%, percentages in other countries have been substantially
62%), perforating vein fistula (PVF) at the elbow (48%, 21%) lower [6, 7].
and non-PVF at the elbow (29%, 17%). Additionally, there has been a rapid growth of elderlyResults. Results of access survival for age groups 65 and
patients starting dialysis therapy [7]. Within the group of65 years, male and female, diabetic and non-diabetic sub-
diabetics, the sub-population of elderly, mainly sufferinggroups ranged from 51 to 75% for unassisted and from 75 to
96% for assisted two year access survival. PVF appeared to from diabetes type-2, shows a particularly steep increase
be advantageous over non-PVF access at the elbow. First inter- in incidence. With the increase of comorbid conditions
vention for peripheral steal syndrome was required at a rate
related to age and diabetes, vascular problems are in-of 7 and 0.6 per 100 patient-years at risk for diabetic and non-
creasingly prevalent as evidenced by progressive periph-diabetic patients, respectively. The thrombosis rates per patient
year of 0.03 for non-diabetics and 0.07 for diabetics are superior eral vascular, carotid and coronary artery disease. Sev-
to previously published results for AV fistulae or for a com- eral publications have stressed the issue that diabetic
bined AV fistula–AV graft approach. patients are more prone to atherosclerotic disease [3, 5].
Conclusions. Potential explanations for these excellent re-
Additionally, damage of the venous vasculature is ob-sults among elderly and diabetic patients include preoperative
served from numerous blood samplings, infusions andevaluation, exclusive use of native vessels, a variable surgical
approach including PVF, and the experience of a single oper- intravenous lines during hospitalizations that often occur
ator. in the late stages of chronic renal disease. Venous dam-
age may thus occur even before the patient is referred
to a nephrologist or access surgeon.
Creation and maintenance of a well functioning vascu- Little information is available on the particular prob-
lar access remains one of the most challenging problems lem of creating vascular access in the diabetic. Adams
in delivering adequate hemodialysis therapy. In 1966, reported on disappointing results with wrist fistulae and
when Brescia and Cimino published their ingenious achieved better results with antecubital fistulae [8]. Feld-
method of a forearm arterio-venous fistula, only young, man et al commented that the appropriate role of bra-
relatively healthy patients were selected for maintenance chial AVF is less certain because of inadequate data [9].
Many authors have recommended primary polytetra-
fluoroethylene (PTFE) bridge grafts for as many as 80%Key words: hemodialysis, vascular access, arteriovenous fistula, throm-
bosis, end-stage renal disease, diabetes, perforating vein fistula. of diabetic patients [10]. Leapman et al concluded that
“the arteriovenous fistula is not a panacea for vascular
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considered for this group of patients on hemodialysis” access placement and for the remainder he was likely
the choice for the more difficult cases. Since 1997, ultra-[11].
However, a high overall complication rate of PTFE sonography was utilized as a routine preoperative inves-
tigation in 80 to 90% of candidates for primary accessgrafts as vascular access is well documented [12, 13] and
has been shown to be significantly higher than the com- operation.
plication rate for native AV fistulae [14]. A recent report
Data collectionalso shows higher death rates in diabetics with a PTFE
vascular access graft than in diabetics with an AV fistula For all patients, reports on the first access creation
including detailed anatomical drawings were available[15].
In view of the evidence of poorer outcomes with PTFE and data were entered into computer assisted documen-
tation (Excel). These files included date and type ofgrafts, the NKF-DOQI Clinical Practice Guidelines for
Vascular Access encourage creation of primary AV fis- surgery, date of birth, gender, renal disease diagnosis,
as well as follow-up dates and description of all diagnos-tulae for the majority of new patients elected to receive
hemodialysis as their initial form of renal replacement tic and therapeutic interventions and surgical revisions.
Follow-up information was supplemented and verifiedtherapy [16]. Achieving this goal is expected to be more
difficult in elderly patients and particularly in diabetic by one of the authors (KK) through personal calls to
all treating dialysis centers. This allowed capture andpatients than in younger non-diabetic patients. Our expe-
rience as reported here, however, suggests that a very integration of data on all interventions and revisions,
even those performed by other surgeons (7.4% of firsthigh rate of AV fistulae and primary access patency can
be achieved even in diabetic patients. We report on the revisions). All phone calls for follow-up at other centers
were done by KK inquiring about (1) each patient’s vitaloutcomes accomplished and strategies used in a single
referral center for vascular access surgery. status, (2) function of the original AV fistula, and (3) all
diagnostic and surgical interventions during the interim.
Phone calls assured 100% response rate and allowed
METHODS
inquiry for more detail as needed. Follow-up of patients
Study design treated at Cologne-Merheim dialysis units was complete
in 97.3% of patients with the remainder censored at lossThis study is a single-center, retrospective evaluation
of all patients undergoing construction of primary arte- to follow-up. Phone calls occurred in two directions on
an as-needed basis and were more frequent with problemriovenous (AV) vascular access for chronic maintenance
hemodialysis. patients. Follow-up data were systematically collected
on all patients in the first four weeks after 12/31/99. All
Patients contact persons were personally known to KK, and most
of them were head nurses. Phone calls were welcomeAll patients with construction of a primary AV vascu-
lar access from January 1, 1993 to December 31, 1998 and the staff were always eager to assist KK.
Angiographic procedures or surgical procedures per-for maintenance hemodialysis treatment were entered
into this study. No patient was transferred to another formed by other operators were captured through re-
cords at the affiliated centers and at all other centerscenter or surgeon for primary AV access creation. How-
ever, patients who had a clinical contraindication for the usually by referral back to the first operator (KK) for
angiography, angioplasty or surgery. Additional ascer-creation of any AV access because of peripheral ischemia
or congestive heart failure had to be excluded. This af- tainment was achieved through phone calls as described
above.fected only a very small minority of patients, who had
to be treated exclusively with a central venous access.
Statistical analysisRetrospectively, the exact number of such exclusions
could not be determined for the population of this study. Analyses were performed at the Kidney Epidemiology
and Cost Center, University of Michigan. In additionOne nephrologist (KK) performed all preoperative
clinical examinations, diagnostic radiological investiga- to basic demographic data, we evaluated the type and
location of first AV vascular access. Cox models andtions and all surgical procedures. All initial surgeries
were performed at Cologne-Merheim by KK. Seventy- Kaplan-Meier curves were used to analyze the primary
outcome of days from access creation to first revisionnine percent of the 748 consecutive patients were treated
at six affiliated dialysis units that were directed by or failure. In agreement with other authors [17], the
secondary or assisted access failure was defined as anynephrologists trained at Cologne-Merheim. The remain-
der (21%) were treated at 42 other dialysis units, 17 of access failure that required switching to an atrial cathe-
ter, creation of a new access on the contralateral arm orthem treated only 1 study patient, 14 of them treated 2
to 5 patients and 11 treated 6 to 19 patients. Thus, for switching to peritoneal dialysis. This definition included
access closure for steal syndrome or heart failure. Pri-79% of patients KK was the only available expert for
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Table 1. Characteristics of the 748 consecutive patients receiving amary intervention-free or unassisted survival was defined
primary permanent vascular access
as time to any type of first event, including revision,
Characteristic Mean or percentangioplasty, any switch to an atrial catheter, or any of
Age mean in years 59.6the secondary access failure events (described above),
Males % 59.1whichever came first. Failure for a fistula to mature was
Cause of ESRD %
rated as a primary access failure, when any secondary Diabetic nephropathy 24.2
Primary glomerular disease 30.7procedure was used. In analyses for each outcome, pa-
Vascular nephropathy 18.5tients were censored at death with functioning AVF,
Urological disease 11.1
transplant, recovered renal function, loss to follow-up, Polycystic kidney diseases 9.5
Systemic diseases 5.6end of study, and modality switch without AVF failure.
Analgesic nephropathy 5.1Kaplan-Meier survival curves were calculated for diabet-
Hereditary/congenital nephropathy 1.6
ics and non-diabetics for assisted and unassisted access Other and unknown 17.8
survival following patients for up to two years. Similar
curves were calculated stratifying on age, sex, and diabe-
tes. Separate Cox models were fit for each sex and diabe-
tes group to evaluate primary and secondary access sur- 567). Censoring for renal transplantation occurred in 5%
of diabetic and 9.5% of non-diabetic patients for thevival overall by access type (forearm, elbow PVF and
elbow non-PVF). These models were adjusted for three analysis of primary access survival. For the analysis of
secondary survival the corresponding percentages wereage categories (10 to 44, 45 to 64 and65 years). Similar
models were evaluated for interactions between age and 5% and 13%.
access type.
Overall access survival
Eighty complete failures were observed among the
RESULTS
748 patients and 243 first revisions were performed dur-
During the years 1993 to 1998, 748 consecutive patients ing the one-to-seven year follow-up period. For the 243
underwent construction of a primary AV access. In no revisions, PTFE prosthetic graft material was used in
case was it necessary to create a primary AV graft and only 17 cases (7%). PTFE was used in an additional 10
in no case was polytetrafluoroethylene (PTFE) material cases in subsequent revisions. Overall, the rate of first
used in these initial accesses. Although KK had substan- revision rate was 0.18 revisions per patient-year, or 18
tial experience with primary PTFE grafts in earlier years revisions per 100 patient-years at risk.
and continued to use PTFE for some repairs, 100% of Table 2 shows the primary and secondary access sur-
patients received a primary AV fistula. No patient was vival for one and two year follow-up among male and
transferred to another center or surgeon for PTFE graft female diabetic and non-diabetic patients by age group
or other primary AV access operation. Follow-up ended (65 and 65). Access survival rates for secondary as-
December 31, 1999. The preferred type of anesthesia sisted survival were of course greater than for primary
was the axillary or brachial plexus block. However, since unassisted survival, since the latter counts as events any
1997, all primary accesses have been placed only under intervention that may precede a failure. For both age
local anesthesia. For one third of the patients the access groups the lowest primary unassisted access survival was
surgery was performed in an outpatient setting. General observed among female non-diabetic patients (51 and
anesthesia was not required for construction of primary 63% for ages 65 and 65 at two years, respectively).
vascular access in any of these primary access surgeries. For ages under 65 years, male non-diabetic patients had
Antibiotics were not given for primary access surgeries, the best primary access survival (75% at two years). For
and anticoagulants or similar medications were not rou- patients aged 65 and older, the best primary unassisted
tinely prescribed. access survival was observed among male diabetics (81%
Of the 748 patients, 181 (24%) had diabetes as their at 1 year, and 72% at 2 years).
cause of ESRD. Patient characteristics including primary Secondary (assisted) access survival for patients under
renal diseases for all patients are shown in Table 1. The 65 years was lowest among male diabetic patients (75%
average age for the diabetic group was five years older at two years), whereas male non-diabetic patients had
than for the non-diabetic group (63 vs. 58 years, P  the best secondary access survival (96% at two years).
0.0001). The male predominance was lower in the dia- For patients 65 and over, the lowest secondary (assisted)
betic than in the non-diabetic group, but the difference access survival was observed among female diabetics
was not significant (54 vs. 61%, P  0.12). During the (80% at 2 years) and the best secondary (assisted) access
1 to 7 year follow-up, 24% of diabetic patients (44 of 181) survival was observed among male and female non-dia-
reached the end of the study without any intervention betics (94 and 92% at 2 years).
Figure 1 shows Kaplan-Meier primary and secondaryor event versus 30% in the non-diabetic group (171 of
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Table 2. Primary and secondary vascular access survival and 95% confidence intervals at one and twp years after first AV fistula placement
by diabetes (DM), sex, and age
Access survival (95% CI)
Patients under 65 years of age Patients 65 years of age and older
N 1 Year 2 Years N 1 Year 2 Years
Primary access survival
Female non-DM 125 67% (58%, 75%) 51% (42%, 61%) 98 73% (64%, 82%) 63% (52%, 74%)
Female DM 28 69% (51%, 87%) 62% (42%, 83%) 55 78% (67%, 90%) 70% (57%, 84%)
Male non-DM 225 85% (80%, 90%) 75% (69%, 81%) 119 77% (69%, 85%) 68% (58%, 78%)
Male DM 59 70% (57%, 83%) 61% (46%, 76%) 39 81% (65%, 96%) 72% (54%, 90%)
Secondary access survival
Female non-DM 125 95% (91%, 99%) 89% (83%, 95%) 98 95% (90%, 99%) 92% (86%, 98%)
Female DM 28 84% (70%, 98%) 84% (70%, 98%) 55 88% (79%, 97%) 80% (67%, 92%)
Male non-DM 225 98% (96%, 100%) 96% (93%, 99%) 119 95% (91%, 99%) 94% (89%, 99%)
Male DM 59 84% (73%, 94%) 75% (61%, 88%) 39 89% (76%, 100%) 84% (69%, 98%)
Fig. 2. Modified perforating vein fistula (PVF) technique.
Fig. 1. Primary and secondary vascular access survival (Kaplan-Meier)
in diabetic (dotted line) and non-diabetic (solid line) patients from time
of first AV fistula placement.
technique is shown in Figure 2. In contrast to the Gracz
approach this modification preserves the deep venous
system by not ligating the deep vein.
(3) Non-perforating vein fistula at the elbow (non-vascular access survival curves for diabetics and non-
PVF). Standard brachio-cephalic or brachio-basilic fis-diabetics followed for up to 2 years. The two-year pri-
tula including a series of variants for this approach.mary (unassisted) vascular access survival for diabetic
Among the 181 diabetic patients the majority (76%)and non-diabetic patients was very similar (67 and 66%
received a primary elbow access with 48% as a PVF andat 2 years, respectively), but non-diabetics had much
29% as a non-PVF elbow fistula, while a forearm accessbetter secondary (assisted) access survival (93 vs. 79%
was created in only 24%. The distribution was different
at 2 years). These results are without statistical adjust-
for non-diabetic patients as shown in Figure 3. Sixty-two
ments. percent of the 567 non-diabetic patients had a forearm
fistula as the primary vascular access. Among the re-Vascular access categories
maining 38% of patients with elbow fistulae, the PVF
The vascular accesses were created using three major (21%) was slightly more common than the non-PVF type
surgical approaches: (17%). Thus, in this experience the most commonly used
(1) Forearm AVF. AV anastomoses using the radial access for diabetic patients was the elbow PVF and for
artery (Brescia and Cimino) or occasionally the ulnar non-diabetics the forearm AV fistula.
artery at the wrist or along the forearm up to approxi-
Outcomes by access typemately 5 cm below the crease of the elbow.
(2) Perforating vein fistula at the elbow (PVF). AV Figure 4 reports a more detailed analysis of primary
anastomosis between the perforating vein and the bra- access survival at one year according to the three types
chial artery, using Konner’s modification of a method of AV fistula for the male and female diabetic and non-
diabetic patient groups. These results are shown for pa-first described by Gracz et al [18]. This modified PVF
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Fig. 3. Distribution of primary vascular ac-
cess categories among patients with ESRD
due to diabetes and non-diabetic causes.
Fig. 4. Primary vascular access survival (un-
assisted) at one year by access type and patient
group for patients aged 45 to 64. Abbreviation
is PVF, perforating vein fistula. Symbols are:
() forearm; () elbow non-PVF; ( ) elbow
PVF; *P  0.05 compared to PVF; †P  0.05
compared to forearm
tients ages 45 to 64 years. The perforating vein fistula survival at one year. Among non-diabetic patients the
results for the forearm AVF is superior to the non-PVF(PVF) at the elbow had a better primary access survival,
when compared to the non-PVF at the elbow, that is, for both males and females (P  0.05). Similarly to pri-
mary access survival, the results for the PVF were better,the brachio-basilic and the brachio-cephalic type. This
particularly among non-diabetics, but the difference wasdifference was significant in three of the four gender
only significant among males. There were no significantby diabetes subgroups (P  0.05). The primary access
access type by age group interactions, again indicatingsurvival for forearm AV fistulae appeared slightly worse
that the relationship among access types was similar forthan for PVF at the elbow but this difference was not
the other age groups. Comparisons between sets of barssignificant in three of the four groups. This superior result
by gender and diabetes groups, however, were not testedfor PVF is striking since the non-PVF is considered the
with this interaction.preferred type of primary AV fistula for patients who
cannot have a forearm AVF due to peripheral vascular
Cause of access failuredisease. There were no significant access types by age
group interactions, which indicates that the pattern of Figure 6 shows complication rates per 100 patient-
years at risk for diabetics and non-diabetics both overalloutcome by access type is similar for the other age
groups. and for the three access types. The thrombosis rates
varied by access type with the lowest rates in the elbowFigure 5 shows secondary rather than primary access
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Fig. 5. Secondary vascular access survival
(assisted) at one year by access type and pa-
tient group for patients aged 45 to 64. Symbols
are: () forearm; () elbow non-PVF; ( )
elbow PVF; *P 0.05 compared to PVF; †P
0.05 compared to forearm.
Fig. 6. Complication rates per 100 patient
years at risk. Rates of peripheral ischemia and
thrombosis as the cause of first revision by
diabetes and access type. Symbols are: ()
forearm; () elbow PVF; ( ) elbow non-PVF;
() overall; *P  0.05 compared to non-dia-
betics overall.
perforating vein fistula group, however, there was no diabetic patients. This rate was only slightly and not
significant difference across access types. Averaged over significantly higher for diabetic patients (20 per 100 pa-
all access types, thromboses accounted for 3 and 7 events tient-years, P  0.78).
per 100 patient-years at risk in diabetic and non-diabetic
patients, respectively, and this overall difference was sta-
DISCUSSIONtistically significant (P  0.01). Early thrombosis within
The present study shows excellent results for assistedthe first month following access placement was observed
and unassisted AV access survival even among new el-in only 1 of the 181 diabetic patients and 18 of the 567
derly and diabetic ESRD patients. This is apparent whennon-diabetic patients.
one considers the DOQI guidelines, which suggest thatPeripheral ischemia due to steal syndrome is a well-
at least 50% of new patients should have an AV fistulaknown complication of AV shunting. The peripheral
and that the rate of thrombosis events for AV graftsischemia rates varied by access type with the lowest rates
should be below 0.5 per patient-year [16]. The presentin the forearm group, however, this difference was not
study shows that AVF may be achievable for over 90%statistically significant. Averaged over all access types,
of ESRD starting hemodialysis and that the thrombosisperipheral ischemia accounted for 7 and 0.6 events per
rate can be as low as 0.03 to 0.07 per patient-year. Little100 patient years at risk in diabetic and non-diabetic
attention has been given in the literature to the challeng-patients, respectively, and this difference was statistically
ing problem of creating and maintaining vascular accesssignificant (P  0.0001).
in elderly and diabetic patients. This is surprising in theAnalyzing the time to first access event, we found a
rate of 17.5 events per 100 patient-years at risk for non- face of the rapidly growing proportion of elderly patients
Konner et al: Success with AV fistulae for HD 335
suffering from diabetes mellitus type 2 where vascular graft material [12, 14], these data confirm the desirability
of using the native vessels even in elderly and diabeticdamage, particularly peripheral arterial disease, is
common. patients.
The selection of only the healthiest patients could haveIn our study, covering all primary AV access opera-
tions during 1993 to 1998, diabetic patients accounted contributed to these excellent results. However, this ex-
planation can be rejected by the fact that the more diffi-for 24% of the patients. In more recent data from the
Dialysis Outcomes Practice Patterns Study, 25% of new cult cases for initial vascular access tended to be referred
to this center and that no patients were referred else-patients in Germany and 41% of new patients in the US
had diabetes as the cause of ESRD [6]. where for access creation. Referral to peritoneal dialysis
needs to be considered also. During the year 2000, 184The results of the present study indicate that AVF
can be created as the initial permanent access in the vast patients started ESRD therapy at this center and 31 of
them (17%) were selected for peritoneal dialysis, whichmajority of incident ESRD patients. Exceptions to this
practice were patients with serious risk of aggravating is somewhat higher than the 5.7% reported for the Ger-
man patients starting ESRD therapy in 1999 [22]. Thepre-existing chronic heart failure (CHF) or causing a
symptomatic steal syndrome according to the pre-opera- experience at Cologne-Merheim cannot be considered
representative for Germany, particularly since this insti-tive clinical assessment. Such patients received a central
venous access or peritoneal dialysis. Since such informa- tution is a referral center for vascular access creation
and for initiating peritoneal dialysis. This experience,tion had not been collected during the study period, we
prospectively evaluated the frequency of these contrain- however shows that superior results can be accomplished
in a large consecutive experience at a referral center.dications to an AV access during the year 2000. Among
the 153 patients who were approaching or initiating dia- We speculate that these excellent results achieved may
be explained by a combination of several factors:lytic therapy and were referred and evaluated for initial
access creation, KK found only 9 patients (5.9%) who The experience of a single operator may have played
a role. One of the authors (KK) is a nephrologist whohad a clinical contraindication for an AV access (AVF or
AVG). Similarly, for the subgroup of 53 diabetic patients had placed primary AV accesses for 18 years before the
start of the present study. Since the spring of 1992, heonly one (2%) could not have an AV access. No patient
from this Medical Center Cologne-Merheim and no pa- placed all AV vascular accesses at this center and also
for patients referred from other centers. Having a singletient referred from elsewhere for primary access was
sent elsewhere for a PTFE graft placement, and no PTFE operating physician completely identified with all out-
comes provides a challenge for him or her to be success-material was used by KK after 1985 for primary AV
accesses. Prior to that year KK had experience with ful and strive for the highest personal standards. Analysis
of failures during prior years of AV access proceduresprimary PTFE grafts and has continued to use PTFE for
access revisions albeit with decreasing frequency during led to a re-evaluation of preoperative investigations, rec-
ognition of the hemodynamics of arteries, veins, and AVthe last decade. Thus, in a vascular access referral center
having prior experience with both AVF and PTFE grafts, fistulae, optimizing the selection of vessels and location
of primary vascular access, and to the surveillance ofwe were able to show that approximately 94% of new
patients could receive an AVF successfully and the re- AV fistula function for the advantages of elective access
revisions. This certainly has been a continuous processmaining 6% required a cuffed central venous catheter
as their primary permanent access. of learning, as an interdisciplinary field in one person.
Adapting surgical technique according to AV physiol-Ascertainment of follow-up was remarkably complete
with only 2.7% of patients requiring censoring because of ogy and pathology may have also played a role. During
the late 1970s, constructing a primary AV fistula at theloss to follow-up. Vascular access events were captured
longitudinally and there was an additional verification wrist was the generally accepted strategy, even for dia-
betic ESRD patients. Location depended exclusively onby personal phone calls from KK for every referred pa-
tient to capture any unreported intervention or failure. the availability of a suitable vein without much regard
to the artery, even when its walls were thickened andThe potential limitation in any outcomes study of under-
ascertainment of events was thus substantially mini- calcified. Rates of early thrombosis were high, arterial
inflow was often inadequate, and cannulation problemsmized.
Large reports on vascular access outcome using exclu- were frequently observed [8]. The reason for this phe-
nomenon is likely related to the initially reduced diame-sively AVF are not available. However, the present re-
sults are far superior to several prior reports of experi- ter of this type of artery, but more importantly to the
lack of the usual substantial arterial dilatation after mat-ences using a combined AVF and PTFE approach
[12–14, 19–20] even with single center experience [21]. uration. Therefore, interest focused on distensibility or
compliance of the arterial wall. A high arterial inflow isIn view of the excellent results with this approach and
the well-documented inferior results when using PTFE required for venous dilatation, which is a prerequisite
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for successful cannulation and adequate dialysis therapy. has the potential risk to induce peripheral ischemia in a
large fraction of these diabetic and older patients. TheThe typical initial blood flow rate in the radial artery of
20 to 30 mL/min increases up to 200 to 300 mL/min traditional choice of access surgeons, therefore, is avoid-
ance of this location of anastomosis in these high-riskimmediately after creation of an AV anastomosis, reach-
ing flow rates of 600 to 1200 mL/min after maturation patient groups. To prevent these complications, the PVF,
originally described by Gracz et al [18], was modified by[23]. Thus, the increasing fistula blood flow rate depends
on arterial dilation and the quality of the arterial wall. one of the authors (KK) by preserving the continuity of
the deep vein. The length of the anastomosis to theThe initial diameter is less important as demonstrated
by the fact that AV fistulae can be successfully created brachial artery is limited to the diameter of the perforat-
ing vein. This diameter is typically 3 to 5 mm. For cre-in children [24]. Therefore, it appears essential to avoid
arteries with thickened arterial walls due to calcification ation of the anastomosis, the technique published by
Tellis et al [28] was usually used. This technique startsor sclerosis of the median layer. Since atherosclerosis is
more pronounced distally [21], a more proximal ap- with suturing the anastomosis in the center of the poste-
rior arterial and venous walls. Suturing is continued pass-proach at the elbow was frequently used in this study
and has proven successful in patients with peripheral ing the corners with excellent visualization throughout
the procedure, which favors precision to connect evenvascular disease [25].
Preoperative evaluation may have played a role. Pre- small diameter vessels as with the PVF-anastomosis. Al-
though our results demonstrate that this procedure couldoperative clinical investigations need to include the eval-
uation of both the venous system and the quality of not completely prevent peripheral ischemia, the rate of
8.2 per 100 patient-years for diabetic patients with elbowarterial vasculature. Careful medical history, palpation,
auscultation and bilateral blood pressure examination PVF is superior to most prior reports. In fact, the PVF
type appeared to have a somewhat lower rate of periph-can provide valuable information. Ultrasonographic
techniques (B-mode, Duplex and/or color Doppler) eral ischemia than the non-PVF elbow fistula. Another
potential benefit of this PVF modification is suggesteddemonstrate the morphology of the great veins and pro-
vide essential data about the diameter, the structure of by the low rate of early thrombosis in the diabetic pa-
tients (none in 86 patients). The success observed withthe wall and flow characteristics of the brachial, radial
and ulnar arteries [26]. We consider ultrasonography a the PVF is likely due to the combination of two reasons,
the use of the perforating vein with the limited lengthmandatory pre-operative procedure that has replaced
the Allen test. Additionally, a simple X-ray of both fore- of the anastomosis and the use of a large-diameter and
less sclerotic artery. Since creation of the PVF meansarms is occasionally used to look for arterial calcifica-
tions. Venography may be indicated in selected cases, using exclusively the venous perforating vein, the total
superficial venous system remains untouched by the op-such as in obese patients. Thus, the decision on type
and location of initial access was individually based on eration and is suitable for cannulation. Furthermore, the
PVF may offer the additional advantage of allowing fu-clinical and on ultrasonographic, in some cases on addi-
tional radiologic findings. ture construction of vascular accesses using the predi-
lated cephalic or basilic vein.This preoperative evaluation resulted in a preference
of the elbow region in 76% of the diabetic patients and The tailored selection of type and location of initial
vascular access appears to be important as suggestedin 38% in the non-diabetic group. With this approach,
we observed a primary unassisted two-year access sur- by the excellent assisted and unassisted primary access
survival rates. The remarkable low thrombosis rate, evenvival for patients older than 65 years that was similar to
that achieved for patients aged less than 65 years. This slightly lower for diabetic patients, may additionally be
a result of continuous surveillance by nephrologists andfinding does not agree with the statement of Astor [27]
that the “potential benefits of AV fistulae over PTFE staff. There is no regularly practiced technical surveil-
lance program used in the dialysis units involved; a fewgrafts are not realized in women and older men.” Al-
though female non-diabetics had the worst outcome for centers perform recirculation studies or Kt/V measure-
ments in cases suspicious for AVF dysfunction. At theassisted survival in the present study, these results are
far superior to those reported even for a combined AVF main center, Cologne-Merheim, evaluations are based
on inspection, palpation and auscultation plus monitor-and AV graft approach. Within the group of older pa-
tients, our results for diabetics were not dissimilar from ing of changes in arterial and/or venous pressures from
baseline levels or prolonged bleeding after post dialysisthose for non-diabetic patients.
The innovative surgical technique of perforating vein removal of a dialysis cannula. Signs for early dysfunction
are monitored more closely. Obvious indications for sur-fistula (PVF) may have contributed to the overall results
and to the ability to place AV fistulae in difficult patients. gical or interventional procedures are acted on by surgi-
cal referral or by intervention by one of the authorsSuturing a vein to a large diameter artery like the bra-
chial artery in the elbow region with a long anastomosis (KK). For less obvious cases ultrasonographic and/or
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angiographic studies are utilized with clear questions to “healthy” vessels, and avoidance of distal arteries, if scle-
the examiner. The aim of this strategy is to care for the rotic or calcified; (4) utilization of perforating vein fistula
failing fistula and to minimize the need for emergency (PVF) to achieve superior access survival rates and re-
procedures for the failed fistula. This approach has led duced frequency of both peripheral ischemia and early
to the finding that 47.5% of first revisions were done thrombosis when using AVF at the elbow; (5) AVF sur-
electively. In fact, 9% of the first revisions had been veillance and early, elective repair.
planned at the time of initial placement, for example, With experience and a “tailored” approach, AV fistu-
subcutaneous transposition of the basilic vein to enlarge lae can be created in the vast majority of new ESRD
cannulation sites. These originally planned revisions patients and outcomes can be excellent. Savings in mor-
were counted as events in the present study. This ap- bidity and cost are expected to be substantial.
proach of elective repair of vascular access for reduction
of thrombosis rates agrees with a report by Sands and ACKNOWLEDGMENTS
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